NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 313 filers reported holding NOVAVAX INC in Q3 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,250,517 | -38.5% | 98,777 | -64.8% | 0.00% | -60.0% |
Q3 2023 | $2,032,073 | -7.3% | 280,673 | +31.7% | 0.01% | -44.4% |
Q4 2022 | $2,191,326 | -22.1% | 213,164 | +38.0% | 0.01% | -35.7% |
Q3 2022 | $2,812,000 | -75.8% | 154,510 | -31.5% | 0.01% | -78.5% |
Q2 2022 | $11,598,000 | +83.5% | 225,518 | +162.9% | 0.06% | +140.7% |
Q1 2022 | $6,319,000 | -40.5% | 85,793 | +15.5% | 0.03% | -6.9% |
Q4 2021 | $10,629,000 | -12.5% | 74,284 | +26.8% | 0.03% | -17.1% |
Q3 2021 | $12,142,000 | -10.0% | 58,569 | -7.9% | 0.04% | -31.4% |
Q2 2021 | $13,496,000 | +389.7% | 63,570 | +157.2% | 0.05% | +142.9% |
Q4 2020 | $2,756,000 | -54.8% | 24,714 | -56.1% | 0.02% | -74.4% |
Q3 2020 | $6,097,000 | +46.6% | 56,271 | +12.7% | 0.08% | +22.4% |
Q2 2020 | $4,160,000 | +576.4% | 49,910 | +10.3% | 0.07% | +318.8% |
Q1 2020 | $615,000 | +257.6% | 45,251 | +4.8% | 0.02% | +1500.0% |
Q4 2019 | $172,000 | – | 43,176 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |